Einstein-Montefiore's internationally recognized hematologists and multidisciplinary experts offer the highest quality care and management of anemias, white cell disorders, platelet problems, thrombosis, and myeloproliferative diseases. more info >>
Discovery May Help Prevent Chemotherapy-Induced Anemia
Combining chemotherapy with nerve-protecting agents may prevent long-term bone marrow injury that causes anemia and improve the success of bone marrow transplants, according to a study led by Dr. Paul Frenette.
The Division of Hematology proudly announces the inception of the Bronx Blood Research Fund, committed to excellence in research and advancing therapy and management of thalassemias and hemoglobinopathies.
Einstein-Montefiore's award-winning hematologists diligently study and conduct trials, including a multi-center clinical study of the correlation of pulmonary hypertension and sickle cell disease, with the quest to develop improved pharmacological agents and effective therapies. more info >>
The Hematology-Oncology Fellowship Program provides outstanding training for those interested in pursuing careers in clinical practice, as well as clinicians who wish to become physician-scientists or clinical scientists with independent academic careers. more info >>
Division information: a message from the Einstein-Montefiore Chief of Hematology, faculty achievements and awards. more info >>